Analysts See $-0.08 EPS for Corbus Pharmaceuticals Holdings, Inc. (CRBP); Codorus Valley Bancorp (CVLY) Shorts Lowered By 7.18%

April 17, 2018 - By Clifton Ray

Codorus Valley Bancorp, Inc. (NASDAQ:CVLY) Logo

Codorus Valley Bancorp Inc (NASDAQ:CVLY) had a decrease of 7.18% in short interest. CVLY’s SI was 33,600 shares in April as released by FINRA. Its down 7.18% from 36,200 shares previously. With 12,600 avg volume, 3 days are for Codorus Valley Bancorp Inc (NASDAQ:CVLY)’s short sellers to cover CVLY’s short positions. The SI to Codorus Valley Bancorp Inc’s float is 0.43%. The stock increased 1.61% or $0.45 during the last trading session, reaching $28.47. About 296 shares traded. Codorus Valley Bancorp, Inc. (NASDAQ:CVLY) has risen 14.41% since April 17, 2017 and is uptrending. It has outperformed by 2.86% the S&P500.

Analysts expect Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) to report $-0.08 EPS on May, 8.They anticipate $0.08 EPS change or 50.00% from last quarter’s $-0.16 EPS. After having $-0.20 EPS previously, Corbus Pharmaceuticals Holdings, Inc.’s analysts see -60.00% EPS growth. The stock decreased 0.48% or $0.0318 during the last trading session, reaching $6.5682. About 172,813 shares traded. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) has declined 38.80% since April 17, 2017 and is downtrending. It has underperformed by 50.35% the S&P500.

Among 5 analysts covering Corbus Pharma (NASDAQ:CRBP), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corbus Pharma had 21 analyst reports since September 8, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained the shares of CRBP in report on Monday, November 6 with “Buy” rating. Aegis Capital initiated Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) on Monday, March 7 with “Buy” rating. The stock has “Buy” rating by Noble Financial on Monday, February 5. The stock of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) has “Buy” rating given on Wednesday, September 20 by Cantor Fitzgerald. The firm earned “Buy” rating on Thursday, December 14 by Cantor Fitzgerald. The stock of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) earned “Buy” rating by Noble Financial on Friday, November 10. The rating was maintained by Noble Financial with “Buy” on Friday, December 15. The rating was initiated by Raymond James on Thursday, January 18 with “Buy”. The firm has “Buy” rating given on Tuesday, June 13 by Cantor Fitzgerald. On Thursday, June 15 the stock rating was maintained by Noble Financial with “Buy”.

Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company has market cap of $375.27 million. The Company’s lead product candidate includes JBT-101, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis, and systemic lupus erythematosus diseases. It currently has negative earnings.

Investors sentiment increased to 4.27 in Q4 2017. Its up 2.27, from 2 in 2017Q3. It improved, as 4 investors sold Codorus Valley Bancorp, Inc. shares while 7 reduced holdings. 9 funds opened positions while 38 raised stakes. 9.47 million shares or 113.56% more from 4.44 million shares in 2017Q3 were reported. Tower Rech Cap Limited Liability Company (Trc) accumulated 1,714 shares. Geode Capital Mgmt Limited Com invested 0% in Codorus Valley Bancorp, Inc. (NASDAQ:CVLY). California Pub Employees Retirement Sys invested in 13,775 shares. National Bank Of America De, a North Carolina-based fund reported 1,437 shares. Vanguard Group has invested 0% in Codorus Valley Bancorp, Inc. (NASDAQ:CVLY). Wells Fargo & Com Mn holds 0% or 15,734 shares in its portfolio. 21,182 were accumulated by Tiaa Cref Inv Mngmt Lc. Legal And General Group Public Lc invested 0% of its portfolio in Codorus Valley Bancorp, Inc. (NASDAQ:CVLY). Citigroup owns 0% invested in Codorus Valley Bancorp, Inc. (NASDAQ:CVLY) for 3,211 shares. Meeder Asset Management Inc invested 0% in Codorus Valley Bancorp, Inc. (NASDAQ:CVLY). Basswood Cap Management Limited owns 125,943 shares or 0.16% of their US portfolio. M&T Bank holds 56,619 shares or 0.01% of its portfolio. Pinnacle Hldg Ltd Liability reported 40,551 shares. Janney Montgomery Scott Ltd Liability Corp owns 11,998 shares for 0% of their portfolio. Wellington Mngmt Group Ltd Liability Partnership invested in 244,488 shares.

Since December 15, 2017, it had 2 insider purchases, and 3 insider sales for $431,423 activity. SWIFT HARRY R ESQ also sold $15,288 worth of Codorus Valley Bancorp, Inc. (NASDAQ:CVLY) shares. On Thursday, February 1 GIAMBALVO JOHN W bought $49,989 worth of Codorus Valley Bancorp, Inc. (NASDAQ:CVLY) or 1,754 shares. The insider UTZ A DWIGHT sold $421,909.

Codorus Valley Bancorp, Inc. (NASDAQ:CVLY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: